{"id":511357,"date":"2021-07-09T08:33:15","date_gmt":"2021-07-09T12:33:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/"},"modified":"2021-07-09T08:33:15","modified_gmt":"2021-07-09T12:33:15","slug":"vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/","title":{"rendered":"VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SOUTH SAN FRANCISCO, Calif., July  09, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1PmBUEkBrPM1YAUkEtKrPZCDXl2XNP_6bSLPZXGjbqFS9c8XnJoQB8PaN_LiDY5bMMaM_dW3TS0whZYi2p0pZ4j40Du-xblTqSV5Aro4wt8=\" rel=\"nofollow noopener\" target=\"_blank\">VistaGen Therapeutics<\/a> (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression, and other central nervous system (\u201cCNS\u201d) disorders, today announced that management will participate in the \u2018Updates in Neuropsych\u2019 panel at the virtual William Blair Biotech Focus Conference 2021 on July 15, 2021 at 9:00 a.m. PT. VistaGen will also be participating in one-on-one meetings throughout the conference.<\/p>\n<p align=\"justify\">\n        <u>William Blair Biotech Focus Conference 2021<\/u>\u00a0\u00a0<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:8%;width:8%;min-width:8%;text-align: justify;vertical-align: middle;vertical-align: middle\">Panel:<\/td>\n<td style=\"max-width:92%;width:92%;min-width:92%;text-align: justify;vertical-align: middle;vertical-align: middle\">Updates in Neuropsych<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: middle\">Date:<\/td>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: middle\">Thursday, July 15 at 9:00 a.m. PT<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: middle\">Webcast:<\/td>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: middle\">\n            <a href=\"https:\/\/wsw.com\/webcast\/blair59\/panel8\/2166208\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/wsw.com\/webcast\/blair59\/panel8\/2166208<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: middle\">Registration:<\/td>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: middle\">To attend the virtual conference, please contact your William Blair representative.<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">The panel will be held virtually, and a live webcast will be accessible through the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UD9wGcY7lvya23my0o0AbJFfmFeptGVqZrLAuG8DSDGEyh2SSxiB0Qn9wCtj8xXU2BlEFqbrCHDKmfmcAfscDGn8JKqS7ZszUyLigyj1URw=\" rel=\"nofollow noopener\" target=\"_blank\">News\/Events<\/a> page of the Investors section of the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EgdTubZD-JApijdmd-DdlabRvtXrAdhmwzEyJP_lKLFSFrnZ1-O-G27gG6BgDhQgMgChaFtyb55y0vwbj3o7JQ==\" rel=\"nofollow noopener\" target=\"_blank\">www.VistaGen.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About VistaGen<\/strong><br \/>\n        <br \/>VistaGen Therapeutics is a biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression, and other CNS disorders. Each of VistaGen&#8217;s three drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date, and has therapeutic potential in multiple CNS markets. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EgdTubZD-JApijdmd-DdlfhQ7G6IcmRN6MLFWiwJXbFaTErjeKYuCXMoxkhF6Qv-Niu_Zi7Hi0k-ProgOEpmEA_Z13Z7J4kaNNp7LSEXcI1_3553N3ymBI75OS0CYsTFk48oiDodkppMDX1Yy3K75mrY9-U5B3fI11M1OxdV9-tVjrEVhftuoIouYgyfReui4dX7Ynxkm__ngaQTDvFJMQV_Jeq4OlM9Zq5IFR_vecA=\" rel=\"nofollow noopener\" target=\"_blank\">www.VistaGen.com<\/a>\u00a0and connect with VistaGen on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BgxK7A-oYV9qiC2r_xITGV1jMBw7-RCJrvDGrN83EnW5OUPcCc75baJZ1chIsAEmVx8_vkaWnTiK1RBC0X3NAdquvY1P9zsK9iFK0wQEsuHKIPgikX4RY9hXqk9N9PDBJcDBdY0swks06nrO6WQmg3pqCa-V1V4R-4rvgZmcgBa2JVO9xBKIW6BpRsHzFqQpgXKcnKw6FNQZ9xFsTKXfHQ==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=P9qaKPLYyk-0jUWL2WnzdWJLzibbvlSgxW5CpcxkY49S15FwGf4GnGwdBJKvWgIH7ovtSqUzJUrE_uZ-_vhodyspmkWfYa4_mSj93nNIRNdNoN1z54Aey60dgtlMClKj8SSufvR-KxlA7BQYS-E9laobjVghMuIbmPYPcvkylt6W2vGCAaygvFf2JRjCF81uEDcaT-6_lOHVOsd9OK9k3SM3dbEjXhgRN3elhukYrXUHCnl02-BSLvyGXtWNgWB_y6nrXn4iKTJKlbgmybi9rw==\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>, and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=u1waGFyWfQUjue2kuyfR9XucsSC0OgCIz491Vs0Q2HEgUVJ9DvJOpbW_p3AC8zpHQt6gKweg5p1E6povTzkHMQPXprfRgr6ElgmwFyYb6x3gXYirZNqQCqmJ-hq7sCcrS1yh-ozLs_fE2aLttTo8CyZnj7cZif-i-9YMPx_y9vGhvRac2LiTUJ6QzgKSgdy16j1cd19tO0X1fUV3hpjthrPPi8GvPMho8JgrXETOsbk=\" rel=\"nofollow noopener\" target=\"_blank\">Facebook<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Company Contacts<\/strong><br \/>\n        <br \/>Mark A. McPartland \/ Mark Flather<br \/>VistaGen Therapeutics, Inc.<br \/>Phone: +1 (650) 577-3606\/+1 (650) 577-3617<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JV3LsWIA3uHJdit34IW7r2g1fvnzkdWCs-P2DKv-iqWOjrL8vG9ByYCAe6XSSB5nMxZBQPAN2k_wsOb6xva5Mg==\" rel=\"nofollow noopener\" target=\"_blank\">IR@vistagen.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NzY4OSM0Mjg5NTIyIzIyMDQzODI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/e105714e-32d6-4792-8e42-5b42ff9751f8\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., July 09, 2021 (GLOBE NEWSWIRE) &#8212; VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression, and other central nervous system (\u201cCNS\u201d) disorders, today announced that management will participate in the \u2018Updates in Neuropsych\u2019 panel at the virtual William Blair Biotech Focus Conference 2021 on July 15, 2021 at 9:00 a.m. PT. VistaGen will also be participating in one-on-one meetings throughout the conference. William Blair Biotech Focus Conference 2021\u00a0\u00a0 Panel: Updates in Neuropsych Date: Thursday, July 15 at 9:00 a.m. PT Webcast: https:\/\/wsw.com\/webcast\/blair59\/panel8\/2166208 Registration: To attend the virtual conference, please contact your William Blair representative. The panel &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-511357","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., July 09, 2021 (GLOBE NEWSWIRE) &#8212; VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression, and other central nervous system (\u201cCNS\u201d) disorders, today announced that management will participate in the \u2018Updates in Neuropsych\u2019 panel at the virtual William Blair Biotech Focus Conference 2021 on July 15, 2021 at 9:00 a.m. PT. VistaGen will also be participating in one-on-one meetings throughout the conference. William Blair Biotech Focus Conference 2021\u00a0\u00a0 Panel: Updates in Neuropsych Date: Thursday, July 15 at 9:00 a.m. PT Webcast: https:\/\/wsw.com\/webcast\/blair59\/panel8\/2166208 Registration: To attend the virtual conference, please contact your William Blair representative. The panel &hellip; Continue reading &quot;VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-09T12:33:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NzY4OSM0Mjg5NTIyIzIyMDQzODI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021\",\"datePublished\":\"2021-07-09T12:33:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\\\/\"},\"wordCount\":253,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NzY4OSM0Mjg5NTIyIzIyMDQzODI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\\\/\",\"name\":\"VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NzY4OSM0Mjg5NTIyIzIyMDQzODI=\",\"datePublished\":\"2021-07-09T12:33:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NzY4OSM0Mjg5NTIyIzIyMDQzODI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3NzY4OSM0Mjg5NTIyIzIyMDQzODI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/","og_locale":"en_US","og_type":"article","og_title":"VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021 - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., July 09, 2021 (GLOBE NEWSWIRE) &#8212; VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression, and other central nervous system (\u201cCNS\u201d) disorders, today announced that management will participate in the \u2018Updates in Neuropsych\u2019 panel at the virtual William Blair Biotech Focus Conference 2021 on July 15, 2021 at 9:00 a.m. PT. VistaGen will also be participating in one-on-one meetings throughout the conference. William Blair Biotech Focus Conference 2021\u00a0\u00a0 Panel: Updates in Neuropsych Date: Thursday, July 15 at 9:00 a.m. PT Webcast: https:\/\/wsw.com\/webcast\/blair59\/panel8\/2166208 Registration: To attend the virtual conference, please contact your William Blair representative. The panel &hellip; Continue reading \"VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-09T12:33:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NzY4OSM0Mjg5NTIyIzIyMDQzODI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021","datePublished":"2021-07-09T12:33:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/"},"wordCount":253,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NzY4OSM0Mjg5NTIyIzIyMDQzODI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/","name":"VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NzY4OSM0Mjg5NTIyIzIyMDQzODI=","datePublished":"2021-07-09T12:33:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NzY4OSM0Mjg5NTIyIzIyMDQzODI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3NzY4OSM0Mjg5NTIyIzIyMDQzODI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vistagen-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/511357","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=511357"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/511357\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=511357"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=511357"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=511357"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}